Rigshospitalet

At Rigshospitalet in Copenhagen, the Dept of Nephrology leads a strong portfolio of studies in kidney disease, renal transplantation, and related metabolic and immune system conditions. Research here focuses on improving treatment effectiveness, protecting kidney function, and refining care for patients with chronic and complex renal disorders.

• IgA nephropathy and proteinuria, with trials testing new ways to reduce kidney damage and preserve function
• Chronic kidney disease, end-stage renal disease, and kidney transplant complications, aimed at improving long-term outcomes
• Hyperglycaemia after renal transplantation, evaluating better control strategies in post-transplant care
• Acute interstitial nephritis and other renal inflammatory conditions, supporting more precise diagnosis and treatment

The site’s nephrology research is closely linked with broader work in immunology, cardiovascular disease, and health care quality, reflecting a multidisciplinary approach to complex patient care.

This hospital-based research program includes major studies in cardiovascular disease, heart failure, and ischemic heart disease. The trials are designed to improve survival, reduce complications, and identify better treatment strategies for patients with acute and chronic heart conditions.

• Myocardial infarction, cardiogenic shock, and cardiac arrest, with studies focused on early treatment and better outcomes
• Atrial fibrillation, aortic stenosis, and coronary artery disease, exploring improved management approaches
• Heart failure and pulmonary hypertension, evaluating therapies that may improve function and quality of life
• Cardiac surgery, including efforts to reduce postoperative risk and enhance recovery

Several studies also examine how to prevent future cardiovascular events, making Rigshospitalet an important center for both acute care and long-term heart disease research.

A large share of the trial activity at Rigshospitalet involves cancer research, especially solid tumors and blood cancers. The studies cover a wide range of diseases and are aimed at testing new therapies, improving survival, and tailoring treatment to tumor biology.

• Breast cancer, ovarian cancer, endometrial cancer, and prostate cancer, with research on more effective treatment options
• Lung cancer, esophageal cancer, and colorectal cancer, including studies in advanced and metastatic disease
• Lymphoma, leukemia, and multiple myeloma, focusing on relapse, resistance, and improved disease control
• Pediatric cancers and rare tumors, where trials aim to expand treatment choices for harder-to-treat diseases

The oncology portfolio also includes work on molecularly targeted treatment and immunotherapy, reflecting a strong emphasis on more personalized cancer care.

The site conducts extensive research in neurological diseases, spanning both common and rare conditions. These trials aim to improve symptom control, slow disease progression, and support better recovery after brain injury or stroke.

• Multiple sclerosis, myasthenia gravis, and neuromuscular disorders, with studies evaluating new treatment approaches
• Alzheimer’s disease and mild cognitive impairment, focused on earlier detection and disease-modifying care
• Stroke, traumatic brain injury, and subarachnoid hemorrhage, where trials seek better acute management and recovery
• Migraine, trigeminal neuralgia, and other headache disorders, testing options to reduce pain and improve daily functioning

This work combines clinical neurology with rehabilitation-oriented research, supporting patients across the full course of neurological illness.

Respiratory diseases, immune-mediated disorders, and infections are another major focus at this Danish research site. The trials aim to improve control of chronic inflammation, reduce infection burden, and strengthen treatment for complex pulmonary conditions.

• Asthma, cystic fibrosis, and bronchiectasis, with studies seeking better long-term disease management
• Pulmonary arterial hypertension and idiopathic pulmonary fibrosis, evaluating therapies that may improve breathing and exercise capacity
• Chronic infections such as COVID-19, tuberculosis-related conditions, and Mycobacterium abscessus pulmonary disease, aiming to improve clearance and outcomes
• Autoimmune diseases including systemic lupus erythematosus, vasculitis, and Sjögren’s disease, where the goal is to better control inflammation

The breadth of this work shows a strong interest in both immune system processes and the clinical impact of chronic lung and infectious diseases.

The research portfolio also includes many trials in pediatric medicine and rare diseases. These studies often address conditions with limited treatment options and aim to improve safety, effectiveness, and quality of life for children and families.

• Childhood leukemia, pediatric brain tumors, and neuroblastoma, with a focus on better cancer control
• Genetic and neuromuscular disorders such as Duchenne muscular dystrophy, spinal muscular atrophy, and Fabry disease
• Congenital and developmental conditions, including achondroplasia, Klinefelter syndrome, and Prader-Willi syndrome
• Rare inflammatory and metabolic diseases, where trials often test new therapies or support earlier diagnosis

This area highlights the site’s role in advancing care for patients with uncommon disorders who often need highly specialized treatment.